跳至主要内容
临床试验/NL-OMON54209
NL-OMON54209招募中不适用

Sirolimus-coated balloon versus drug-eluting stent in native coronary vessels - TRANSFORM II

Fondazione Ricerca e Innovazione Cardiovascolare, No profit organization0 个研究点目标入组 315 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
315

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • age >18 years; -all patients with a clinical indication to PCI (stable
  • coronary arterydisease or acute coronary syndromes); -native coronary artery
  • lesion in a vessel with diameter >2.0 mm and *3.5 mm at visual estimation; -
  • maximum lesion lenght: 50 mm. - informed consent to participate in the study

排除标准

  • target lesion/vessel with any of the following characteristics: - concomitant
  • PCI at the same vessel with any device (vessels are considered: left anterior
  • descending, circumflex or right coronary artery); - pre-dilatation of the
  • target lesion not performed or not successful (residual stenosis >30%); -
  • severe calcification of the target vessel, at lesion site but also proximally;
  • - highly tortuous vessel which could impair device delivery to the lesion site
  • following Investigator*s judgement; - previous stent implantation at target
  • vessel (left anterior descending artery; circumflex artery; right coronary
  • artery); - bifurcation lesion where side branch treatment is anticipated; -
  • left main stem stenosis >50%; - target lesion is in left main stem. -Lesion
  • is located within asaphenous vein graft

研究者

发起方
Fondazione Ricerca e Innovazione Cardiovascolare, No profit organization

相似试验